Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Labcorp Holdings ( (LH) ).
Labcorp Holdings Inc., a major global laboratory services provider, plans to release its financial results for the first quarter of 2026 before the U.S. market opens on Thursday, April 30, 2026, and will host a webcast at 9:00 a.m. ET that day to discuss the numbers. The company will post the earnings release and detailed financial materials, along with a replay of the webcast available for one year, on its investor relations website, signaling transparency and continued engagement with investors around its performance and outlook.
The announcement, issued from Burlington, N.C., on March 31, 2026, underscores Labcorp’s focus on timely communication of quarterly results as it operates at significant scale, having supported a majority of recent FDA drug approvals and conducted hundreds of millions of tests globally. Investors and industry stakeholders will scrutinize the upcoming first-quarter disclosure for insight into demand trends in diagnostics and drug development services, as well as Labcorp’s positioning amid ongoing healthcare and biopharma activity.
The most recent analyst rating on (LH) stock is a Hold with a $280.00 price target. To see the full list of analyst forecasts on Labcorp Holdings stock, see the LH Stock Forecast page.
Spark’s Take on LH Stock
According to Spark, TipRanks’ AI Analyst, LH is a Neutral.
The score is driven primarily by solid (but uneven) financial performance and a constructive earnings outlook with guided growth, backlog strength, and margin initiatives. These positives are partially offset by a weak technical trend and only average valuation support, while recent financing-related corporate actions are modestly positive but keep leverage in focus.
To see Spark’s full report on LH stock, click here.
More about Labcorp Holdings
Labcorp Holdings Inc. is a global provider of innovative and comprehensive laboratory services, supporting doctors, hospitals, pharmaceutical companies, researchers and patients with diagnostic testing and drug development capabilities. The company employs nearly 71,000 people in about 100 countries, supported over 85% of FDA drug and therapeutic approvals in 2025, and conducts more than 750 million tests annually worldwide.
Through its scale and scientific expertise, Labcorp plays a central role in both routine and specialized diagnostics as well as clinical development for new therapies, positioning it as a key infrastructure provider in the healthcare and life sciences ecosystem. Its broad client base and global operational footprint make its financial performance and strategic direction closely watched by healthcare stakeholders and investors.
Average Trading Volume: 699,672
Technical Sentiment Signal: Buy
Current Market Cap: $21.72B
For detailed information about LH stock, go to TipRanks’ Stock Analysis page.